PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Real-time biopsies uncover hidden response to glioblastoma therapy

Early clinical trial results show that serial brain biopsies reveal immune activity in brain cancer not captured by standard scans

2025-10-08
(Press-News.org) (CAMBRIDGE, MASS.) October 08, 2025 – A new study led by Break Through Cancer’s Accelerating Glioblastoma (GBM) Therapies Through Serial Biopsies TeamLab has revealed that an engineered virus therapy, CAN-3110, triggered powerful immune responses deep inside glioblastoma tumors that were invisible to standard imaging like MRI, according to early analyses of two patients with recurrent GBM.

Published today in Science Translational Medicine, the research highlights the TeamLab’s innovative approach of combining serial brain biopsies (tiny pieces of brain tissue removed while a patient is being treated) with advanced multi-omics analyses, can uncover dynamic changes in recurrent GBM. This is the first time scientists have mapped, in high-resolution, how oncolytic virus therapy reshaped the brain microenriornment in real-time.

The study involved two patients with recurrent GBM who underwent serial biopsies over four months of CAN-3110 treatment. Not only was the procedure well tolerated in these patients, but it also enabled an unprecedented level of insight into how tumors evolve during therapy. Standard practice is to not sample a patient’s brain tumor as they undergo treatment rather, to sample only before treatment and then measure responses using MRI. But these findings suggest that this thinking and practice may need to change to revolutionize how patients can monitor their disease. Completion of the trial is required to help answer this question.

“This gives us a real-time window into what is happening inside the tumor,” said Dr. E. Antonio Chiocca, MD, PhD, senior author and Chair of Neurosurgery at Brigham and Women’s Hospital. “Instead of guessing whether a therapy is working based on scans alone, we now have a molecular map that shows how and where the immune system is engaging with the tumor.”

While MRI scans appeared to show tumor growth, deeper molecular analyses told a different story. “This study challenges how we approach radiographic progression in glioblastoma” said Dr. Chiocca.

Using single-cell RNA sequencing, proteomics, immunopeptidomics, AI-enabled digital pathology and immune cell profiling, researchers observed a significant decrease in tumor cell content near virus injection sites. In their place, immune cells (including activated CD8+ and CD4+ T cells) proliferated and mounted targeted responses against both viral antigens and glioblastoma-specific markers. “In this study we show that the immune system can be trained to recognize and attack tumor cells through repeated viral therapy, even when imaging suggests failure.”

The study is an early read-out of an ongoing clinical trial, part of a larger collaborative effort supported by Break Through Cancer, uniting researchers from leading institutions including Dana-Farber Cancer Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Memorial Sloan Kettering Cancer Center, MIT’s Koch Institute for Integrative Cancer Research, and The University of Texas MD Anderson Cancer Center to intercept and cure the deadliest cancers.

The findings signal a future model for glioblastoma research, one where treatment is guided not just by what can be seen on a scan, but by what is happening at the cellular and molecular level inside the tumor itself. This approach could help accelerate the development of more effective therapies for a disease for which progress has been stagnant for decades.

“This study reflects the kind of transformative collaboration Break Through Cancer was created to enable. It opens the door to smarter, more adaptive treatment strategies that can improve how new treatments are assessed and developed for patients with this devastating disease. “Tyler Jacks, PhD, President of Break Through Cancer.

# # #

About Break Through Cancer

Founded in 2021, Break Through Cancer empowers outstanding researchers and physicians to both intercept and find cures for several of the deadliest cancers by stimulating radical collaboration among outstanding cancer research institutions, including its founding partners: Dana-Farber Cancer Institute, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Memorial Sloan Kettering Cancer Center, MIT’s Koch Institute for Integrative Cancer Research, and The University of Texas MD Anderson Cancer Center.

The Foundation is supported by a Board of Directors from the five partner institutions and a Scientific Advisory Board of U.S. cancer experts. The Foundation was launched with an extraordinary challenge pledge of $250 million from Mr. and Mrs. William H. Goodwin, Jr. and their family, and the estate of William Hunter Goodwin III.

For further information, please visit the Foundation’s website at www.breakthroughcancer.org.

END



ELSE PRESS RELEASES FROM THIS DATE:

Repeated brain tumor sampling uncovers treatment response in patients with glioblastoma

2025-10-08
A multi-institutional study from the Accelerating GBM Therapies Through Serial Biopsies TeamLab, led by investigators from the Mass General Brigham Cancer Institute, found that serially testing tumor samples can help detect when a cancer treatment is activating the immune system in recurrent glioblastoma (GBM), even when traditional imaging measures cannot. Their results are published in Science Translational Medicine.   GBM is the most aggressive type of brain cancer, known for growing and spreading quickly. It is challenging to treat and almost always comes back. But it can be hard to understand ...

Novel immunotherapy combination destroys colorectal liver metastases

2025-10-08
Advanced colon cancer is the leading cause of cancer-related death in young American men and the second highest worldwide. In the majority of these patients, as the cancer advances it metastasizes to the liver. Despite progress in surgical therapies aimed at eradicating the cancer, many of these patients will have tumor recurrence in the liver. Now, researchers from UC San Francisco (UCSF), have discovered that a novel combination of immunotherapies can reprogram the immune environment of colon cancer tumors that spread to the liver. In preclinical models, this therapy often eliminated tumors entirely, offering a potential new path for ...

Farmed totoaba could curb poaching

2025-10-08
(Santa Barbara, Calif.) — The trade of totoaba has all the intrigue of a crime thriller. Dollars and drugs change hands as a criminal cartel vies against the government. Communities and endangered species are caught in the crosshairs of a lucrative illicit trade. It may then come as a surprise that the totoaba is a fish. The totoaba is a large, yet unassuming, species of fish native to the Gulf of California. But its mundane appearance belies incredible value on the black market. “Totoaba swimbladder can sell for up to $80,000 USD per kilogram ...

Avalanches: user-carried safety device increases survival time fivefold

2025-10-08
When the Norwegian company that manufactures the Safeback SBX device which is already on the market, approached Eurac Research to have it independently tested, it was clear that the international research team led by physician and researcher Giacomo Strapazzon would publish the results of the study in any case, regardless of the outcome. For the researchers, the experiment posed a significant challenge, as many participants were completely buried in snow, raising concerns that over two-thirds might require urgent excavation. The volunteer group – composed entirely of enthusiastic ski mountaineers, roughly half of them women – ranged from ...

It’s all in your head: Select neurons in the brainstem may hold the key to treating chronic pain

2025-10-08
Acute or short-lived pain, despite its bad reputation, is usually a lifesaver. It acts as a transient negative sensory experience that helps us avoid danger. Touch a hot stove, stub a toe, or bonk your head on a low branch, and the nervous system cues up an “Ow!” Over time, the sting fades, the wound heals, but the lesson sticks. Chronic pain is different; the alarm keeps blaring long after the fire is out, and then the pain itself becomes the problem. Nearly 50 million people in the United ...

Time-restricted eating can boost athletes' health and performance

2025-10-08
  According to a study by researchers at the Universitat Oberta de Catalunya (UOC), time-restricted feeding can have a positive impact on athletes in terms of both their health and performance. The effects of time-restricted eating – where food intake is permitted within a restricted window ranging from 3-4 to 10-12 hours – have been widely studied in the general population, where they have been shown to increase life expectancy, but there is little evidence on its positive effects on high-performance athletes. The study – "Effect of time-restricted feeding ...

Burning issue: study finds fire a friend to some bees, a foe to others

2025-10-08
New Curtin University research has found the impact of bushfires and prescribed burns on global bee populations is highly varied, with some species benefiting from fire while others face severe risks.   The study, led by Adjunct Research Fellow Dr Kit Prendergast from Curtin’s School of Molecular and Life Sciences, examined 148 studies from around the world to understand how fire impacts bees.   The review considered the severity, frequency and duration of fires, along with the different characteristics of bees, such as where they ...

Insights from 15 years of collaborative microbiome research with Indigenous peoples in the Peruvian Amazon

2025-10-08
Forming sustainable research partnerships with Indigenous peoples requires trust and mutual benefit, say microbiome researchers in an opinion paper publishing October 8 in the Cell Press journal Trends in Microbiology. The paper presents a framework for building this type of relationship based on insights from the team’s 15-year-long collaboration with the Matsés, a group of people who live in the Amazon rainforest on the border of Peru and Brazil. To build trust, the researchers worked in collaboration with the Matsés through all stages of the research project, from developing research methods to disseminating results.  “Establishing genuine partnerships with ...

Designing polymers for use in next-generation bioelectronics

2025-10-08
Engineered polymers hold promise for use in next generation technologies such as light-harvesting devices and implantable electronics that interact with the nervous system – but creating polymers with the right combination of chemical, physical and electronic properties poses a significant challenge. New research offers insights into how polymers can be engineered to fine-tune their electronic properties in order to meet the demands of such specific applications. “Silicon-based electronics have been around for decades, and we have a thorough understanding of the electronic properties of materials used in those technologies,” says Aram Amassian, co-corresponding author of ...

Losing Nemo: Almost all aquarium fish in the US are caught in the wild

2025-10-08
New research has revealed that about 90 percent of marine aquarium fish sold by online retailers in the United States are sourced directly from wild populations, mostly in the western Pacific and Indian Ocean. With the US accounting for around two-thirds of all global aquarium fish imports, researchers warn that this reliance on wild capture threatens the sustainability of coral reef ecosystems and puts endangered and threatened species at greater risk of extinction. The research, led by postdoctoral research associate Dr Bing Lin from the University of Sydney’s Thriving Oceans Research Hub in the School of Geosciences, analysed data from four major US-based online aquarium ...

LAST 30 PRESS RELEASES:

Bringing modern science to vitamin biology: Isha Jain wins NIH Transformative Research Award

University of Houston scientists learn that rare bacterium ‘plays dead’ to survive

Introduced animals change how island plants spread, new global study finds

Mayo Clinic researchers discover ‘traffic controller’ protein that protects DNA, and may help kill cancer cells

Protein sidekick exhibits dual roles in stress granule assembly and disassembly

New hope for MS

Kennesaw State professor receives grant to study cancer origins

Pain and antidepressant drug combo linked to increased seizure risk in older adults

Cancer researchers shape new strategies for immunotherapy

Physical exercise can ‘train’ the immune system

Calm red brocket deer can learn to "Come" and other commands - but the flightiest, most restless individuals struggle

China, the world's largest tea producer, is predicted to experience increases in land suitable for tea-growing under climate change, with the overall range shifting northwards, per AI modeling study

Composing crews for Mars missions

Early humans butchered elephants using small tools and made big tools from their bones

1,000-year-old gut microbiome revealed for young man who lived in pre-Hispanic Mexico

Bears and pandas in captivity develop significantly different gut microbiomes compared to their wild counterparts, and giant pandas in particular have less diverse microbiomes than their wild counterp

Prenatal and postnatal support apps might not work

Dancing dust devils trace raging winds on Mars

Raging winds on Mars

Real-time biopsies uncover hidden response to glioblastoma therapy

Repeated brain tumor sampling uncovers treatment response in patients with glioblastoma

Novel immunotherapy combination destroys colorectal liver metastases

Farmed totoaba could curb poaching

Avalanches: user-carried safety device increases survival time fivefold

It’s all in your head: Select neurons in the brainstem may hold the key to treating chronic pain

Time-restricted eating can boost athletes' health and performance

Burning issue: study finds fire a friend to some bees, a foe to others

Insights from 15 years of collaborative microbiome research with Indigenous peoples in the Peruvian Amazon

Designing polymers for use in next-generation bioelectronics

Losing Nemo: Almost all aquarium fish in the US are caught in the wild

[Press-News.org] Real-time biopsies uncover hidden response to glioblastoma therapy
Early clinical trial results show that serial brain biopsies reveal immune activity in brain cancer not captured by standard scans